NABOTA - Trademark Details
Status: 711 - Cancelled - Section 7
Image for trademark with serial number 85902409
Serial Number
85902409
Registration Number
4535957
Word Mark
NABOTA
Status
711 - Cancelled - Section 7
Status Date
2021-01-14
Filing Date
2013-04-12
Registration Number
4535957
Registration Date
2014-05-27
Mark Drawing
4000 - Standard character mark Typeset
Published for Opposition Date
2014-03-11
Attorney Name
Law Office Assigned Location Code
L30
Employee Name
GILBERT, REBECCA L
Statements
Indication of Colors claimed
Color is not claimed as a feature of the mark.
Goods and Services
Botulinum toxin for medical use for use in the treatment of glabellar lines, muscular rigidity, blepharospasm, cervical dystonia, hyperhidrosis, strabismus, prostate disorder, migraine headache, urge incontinence, urinary retention that is secondary to a hypertrophied bladder neck, recalcitrant voiding dysfunction, urge incontinence, neurogenic bladder dysfunction, pelvic pain and urge type dysfunction; Pharmaceutical preparations, namely, acne medications, acne treatment preparations, adrenal hormone preparations, alcohol for topical use, allergy and allergy relief medications, analgesics, androgen preparations, anesthetics for surgical and non-surgical use, antacids, bactericides, antiarrhythmics, antibiotics, anticoagulants, anticonvulsants, antidepressants, antidiabetic preparations, antivirals, anti-cancer preparations, anti-infectives, anti-inflammatories, antipyretics, antibacterial pharmaceuticals, calcium channel blockers, beta blockers, chemical compounds for drug delivery, eye drops, eye patches for medical purposes, hair growth stimulants, vaccines, vaccine adjuvants, vaccine stabilizers, diuretics, amino acids for medical purposes; Medicines for the treatment of gastrointestinal diseases; chemical preparations for pharmaceutical purposes for the treatment of glabellar lines, muscular rigidity, blepharospasm, cervical dystonia, hyperhidrosis, strabismus, prostate disorder, migraine headache, urge incontinence, urinary retention that is secondary to a hypertrophied bladder neck, recalcitrant voiding dysfunction, urge incontinence, neurogenic bladder dysfunction, pelvic pain and urge type dysfunction; chemico-pharmaceutical preparations for the treatment of glabellar lines, muscular rigidity, blepharospasm, cervical dystonia, hyperhidrosis, strabismus, prostate disorder, migraine headache, urge incontinence, urinary retention that is secondary to a hypertrophied bladder neck, recalcitrant voiding dysfunction, urge incontinence, neurogenic bladder dysfunction, pelvic pain and urge type dysfunction; drugs for medical purposes for the treatment of glabellar lines, muscular rigidity, blepharospasm, cervical dystonia, hyperhidrosis, strabismus, prostate disorder, migraine headache, urge incontinence, urinary retention that is secondary to a hypertrophied bladder neck, recalcitrant voiding dysfunction, urge incontinence, neurogenic bladder dysfunction, pelvic pain and urge type dysfunction; Medicines for human purposes for the treatment of glabellar lines, muscular rigidity, blepharospasm, cervical dystonia, hyperhidrosis, strabismus, prostate disorder, migraine headache, urge incontinence, urinary retention that is secondary to a hypertrophied bladder neck, recalcitrant voiding dysfunction, urge incontinence, neurogenic bladder dysfunction, pelvic pain and urge type dysfunction; pharmaceutical preparations for activating cellular function; Adjuvants for medical purposes; pharmaceutical preparations for central nerve treatment; pharmaceutical preparations for diagnosis; dermatological pharmaceutical products; pharmaceutical preparations for treating skin disorders; antibiotic preparations; pharmaceutical preparations for respiratory organs; pharmaceutical preparations for chemical disorder treatment
Classification Information
International Class
005 - Pharmaceutical, veterinary and sanitary preparations; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides. - Pharmaceutical, veterinary and sanitary preparations; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes
006, 018, 044, 046, 051, 052
Class Status Code
1 - Sec. 7(d) - Entire Registration
Class Status Date
2021-01-14
Primary Code
005
Correspondences
Name
John M. Kim
Address
Please log in with your Justia account to see this address.
Foreign Application Information
Filing DateApplication NumberCountryForeign Priority Claim In
2012-12-2140-2012-0079South KoreaTrue
Trademark Events
Event DateEvent Description
2013-04-16NEW APPLICATION ENTERED IN TRAM
2013-04-18NEW APPLICATION OFFICE SUPPLIED DATA ENTERED IN TRAM
2013-07-29ASSIGNED TO EXAMINER
2013-07-30NON-FINAL ACTION WRITTEN
2013-07-30NON-FINAL ACTION E-MAILED
2013-07-30NOTIFICATION OF NON-FINAL ACTION E-MAILED
2013-12-30TEAS RESPONSE TO OFFICE ACTION RECEIVED
2014-01-21ASSIGNED TO LIE
2014-01-28CORRESPONDENCE RECEIVED IN LAW OFFICE
2014-01-28TEAS/EMAIL CORRESPONDENCE ENTERED
2014-01-29APPROVED FOR PUB - PRINCIPAL REGISTER
2014-02-04LAW OFFICE PUBLICATION REVIEW COMPLETED
2014-02-19NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
2014-03-11PUBLISHED FOR OPPOSITION
2014-03-11OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
2014-05-27REGISTERED-PRINCIPAL REGISTER
2019-05-27COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED
2020-10-19TEAS CHANGE OF OWNER ADDRESS RECEIVED
2020-10-19TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
2020-10-19ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
2020-10-19TEAS CHANGE OF CORRESPONDENCE RECEIVED
2020-10-19APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
2020-10-19TEAS SECTION 7 SURRENDER RECEIVED
2021-01-08CASE ASSIGNED TO POST REGISTRATION PARALEGAL
2020-10-19REQUEST FOR SECT 7 TOTAL SURRENDER FILED
2021-01-14CANCELLED SECTION 7-TOTAL
2021-01-15NOTICE OF CANCELLATION SEC. 7 SURRENDER EMAILED